- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03693599
Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean
Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage in Obese Women Undergoing Elective Cesarean Delivery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A double-blind randomized study conducted on 1200 obese pregnant subjected randomly either to single 100 μg IV dose of carbetocin (600 women) or combination of 5 IU oxytocin and 0.5 mg ergometrine (600 women) after fetal extraction and before placental removal.
Prevention of postpartum haemorrhage (PPH) after cesarean section (CS) had been evaluated by measurement of drop of Hemoglobin and hematocrit, incidence of PPH and number of subjects needed additional oxytocic
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Giza, Egypt, 11231
- Faculty of Medicine Cairo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All participants are at 37 - 40 weeks of gestational age
- Noncomplicated pregnancy.
- obese women with BMI > 30.
Exclusion Criteria:
- Participants with placenta previa,
- coagulopathy,
- preeclamptic
- known sensitivity to carbetocin,oxytocin or methergine were excluded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: carbetocin
600 women received single 100 µg IV dose of carbetocin diluted in 10 ml of Ringer's lactate solution (Pabal, Ferring Pharmaceuticals Ltd, West Drayton, UK).
|
single 100 µg IV dose of carbetocin diluted in 10 ml of Ringer's lactate solution (Pabal, Ferring Pharmaceuticals Ltd, West Drayton, UK).
|
ACTIVE_COMPARATOR: Syntometrine
600 women received one ampoule of syntometrine (Novartis, Basel, Switzerland), which consisted of 5 IU of oxytocin and 500 micrograms of ergometrine diluted in 10 ml of Ringer's lactate solution and was administered intravenously over 2 minutes
|
one ampoule of syntometrine (Novartis, Basel, Switzerland), which consisted of 5 IU of oxytocin and 500 microgram of ergometrine diluted in 10 ml of Ringer's lactate solution and was administered intravenously over 2 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
incidence of postpartum hemorrhage after CS
Time Frame: 24 hours
|
Number of participants experienced massive postpartum hemorrhage
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
side effects of drugs used
Time Frame: 24 hours
|
GIT side effects as nausea , vomiting
|
24 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- carbetocin
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Partum Hemorrhage
-
Yariv yogevRabin Medical CenterUnknownPost-Partum Hemorrhage
-
Laboratoire français de Fractionnement et de BiotechnologiesCompleted
-
Hackensack Meridian HealthCompletedPost-partum Hemorrhage (PPH)United States
-
Tampere University HospitalCompletedBlood Transfusion | Post-partum HemorrhageFinland
-
University Hospital, MontpellierNot yet recruitingPost Partum Haemorrhage
-
Oxytone Bioscience BVTerminatedPost Partum HaemorrhageSweden
-
North Bristol NHS TrustFerring Pharmaceuticals; University of Bristol; University Hospitals Bristol... and other collaboratorsCompleted
-
Qazvin University Of Medical SciencesCompletedPost Partum HaemorrhageIran, Islamic Republic of
-
University of BirminghamKing's College London; University College, London; University of Nairobi; World... and other collaboratorsCompletedPost-Partum HaemorrhageSouth Africa, Kenya, Tanzania, Nigeria
-
Hospices Civils de LyonUnknownPost Partum HaemorrhageFrance
Clinical Trials on carbetocin
-
Ciusss de L'Est de l'Île de MontréalCompletedCesarean Section Complications | Hemodynamic InstabilityCanada
-
University Hospital, Basel, SwitzerlandObstetric Anaesthetists' Association United KingdomCompletedAnesthesia; Reaction | Complications; Cesarean SectionSwitzerland
-
Levo Therapeutics, Inc.CompletedPrader-Willi SyndromeUnited States, Canada, Australia
-
University of British ColumbiaEdwards LifesciencesCompletedPregnancy | Effect of Carbetocin on Cardiovascular SystemCanada
-
Bezmialem Vakif UniversityCompleted
-
Cairo UniversityCompletedAbdominal MyomectomyEgypt
-
Cairo UniversityRecruitingPostpartum HemorrhageEgypt
-
Sohag UniversityAl-Azhar UniversityUnknownPostpartum HemorrhageEgypt
-
National University Hospital, SingaporeNational Healthcare Group, SingaporeCompleted
-
Cairo UniversityCompletedPost Partum Hemorrhage | Obesity, MaternalEgypt